Brown Douglas Matthew's Form 4 filing
Neogenomics Inc (NEO) · filed Nov 26, 2021
- Accession no.
- 0001077183-21-000249
- Filed
- Nov 26, 2021
- Trade date
- Nov 23-26, 2021
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.70M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brown Douglas MatthewCIK 0001849414 | Officer (Chief Strategy Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 23, 2021 | Common Stock | SSaleDisposed | −33,333 | $37.19 | −$1,239,654.27 | 78,311 | Direct | |
| Nov 24, 2021 | Common Stock | SSaleDisposed | −33,333 | $36.84 | −$1,227,987.72 | 44,978 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −33,334 | $36.85 | −$1,228,357.9 | 11,644 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.